Perrigo Company plc - stock earnings
PRGO Upcoming estimated earnings
Date | Low Revenue | Average Revenue | High Revenue |
---|---|---|---|
May 7, 2024 BeforeMarket | 1.1 billion | 1.1 billion | 1.1 billion |
PRGO Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -32.3 million USD | 1.2 billion USD |
2023Q3 | 14.2 million USD | 1.1 billion USD |
2023Q2 | 8.4 million USD | 1.2 billion USD |
2023Q1 | -1.1 million USD | 1.2 billion USD |
2022Q4 | -12.7 million USD | 1.2 billion USD |
2022Q3 | -52.1 million USD | 1.1 billion USD |
2022Q2 | -64.9 million USD | 1.1 billion USD |
2022Q1 | -1.3 million USD | 1.1 billion USD |
2021Q4 | 9.6 million USD | 1.1 billion USD |
2021Q3 | -58.9 million USD | 1.0 billion USD |
2021Q2 | -57.7 million USD | 981.1 million USD |
2021Q1 | 38.1 million USD | 1.0 billion USD |
2020Q4 | -175.0 million USD | 1.3 billion USD |
2020Q3 | -154.6 million USD | 1.2 billion USD |
2020Q2 | 60.6 million USD | 1.2 billion USD |
2020Q1 | 106.4 million USD | 1.3 billion USD |
2019Q4 | -19.0 million USD | 1.3 billion USD |
2019Q3 | 92.2 million USD | 1.2 billion USD |
2019Q2 | 9.0 million USD | 1.1 billion USD |
2019Q1 | 63.9 million USD | 1.2 billion USD |
2018Q4 | 81.4 million USD | 1.2 billion USD |
2018Q3 | -67.5 million USD | 1.1 billion USD |
2018Q2 | 36.2 million USD | 1.2 billion USD |
2018Q1 | 80.8 million USD | 1.2 billion USD |
2017Q4 | 73.2 million USD | 1.3 billion USD |
2017Q3 | 44.5 million USD | 1.2 billion USD |
2017Q2 | -69.6 million USD | 1.2 billion USD |
2017Q1 | -2.6 billion USD | 1.1 billion USD |
2016Q4 | -2.6 billion USD | 1.1 billion USD |
2016Q3 | -1.3 billion USD | 1.4 billion USD |
2016Q2 | 194.3 million USD | 1.5 billion USD |
2016Q1 | -133.1 million USD | 1.4 billion USD |
2015Q4 | -107.0 million USD | 1.4 billion USD |
2015Q3 | 112.6 million USD | 1.3 billion USD |
2015Q2 | 56.4 million USD | 1.5 billion USD |
2015Q1 | -94.9 million USD | 1.0 billion USD |
2014Q4 | 70.2 million USD | 1.1 billion USD |
2014Q3 | 96.3 million USD | 951.5 million USD |
2014Q2 | 131.9 million USD | 1.1 billion USD |
2014Q1 | 48.1 million USD | 1.0 billion USD |
2013Q4 | -86.0 million USD | 979.0 million USD |
2013Q3 | 111.4 million USD | 933.4 million USD |
2013Q2 | 118.4 million USD | 967.2 million USD |
2013Q1 | 111.9 million USD | 919.8 million USD |
2012Q4 | 106.0 million USD | 883.0 million USD |
2012Q3 | 105.6 million USD | 769.8 million USD |
2012Q2 | 115.7 million USD | 831.8 million USD |
2012Q1 | 115.7 million USD | 778.0 million USD |
2011Q4 | 99.7 million USD | 838.2 million USD |
2011Q3 | 70.5 million USD | 725.3 million USD |
2011Q2 | 85.6 million USD | 704.6 million USD |
2011Q1 | 89.1 million USD | 691.6 million USD |
2010Q4 | 90.2 million USD | 717.5 million USD |
2010Q3 | 74.4 million USD | 641.3 million USD |
2010Q2 | 49.4 million USD | 619.4 million USD |
2010Q1 | 60.9 million USD | 538.3 million USD |
2009Q4 | 50.9 million USD | 583.2 million USD |
2009Q3 | 61.3 million USD | 528.0 million USD |
2009Q2 | 35.2 million USD | 508.2 million USD |
2009Q1 | 45.9 million USD | 505.9 million USD |
2008Q4 | 25.0 million USD | 561.5 million USD |
2008Q3 | 38.0 million USD | 480.2 million USD |
2008Q2 | 27.5 million USD | 500.2 million USD |
2008Q1 | 40.0 million USD | 503.7 million USD |
2007Q4 | 34.3 million USD | 435.5 million USD |
2007Q3 | 34.0 million USD | 382.7 million USD |
2007Q2 | 18.8 million USD | 374.3 million USD |
2007Q1 | 17.1 million USD | 362.3 million USD |
2006Q4 | 21.1 million USD | 370.6 million USD |
2006Q3 | 16.9 million USD | 340.2 million USD |
2006Q2 | 12.3 million USD | 355.1 million USD |
2006Q1 | 20.9 million USD | 332.3 million USD |
2005Q4 | 25.4 million USD | 359.7 million USD |
2005Q3 | 12.9 million USD | 319.7 million USD |
2005Q2 | -7.0 million USD | 324.5 million USD |
2005Q1 | -379.4 million USD | 220.1 million USD |
2004Q4 | 15.8 million USD | 251.7 million USD |
2004Q3 | 17.6 million USD | 227.7 million USD |
2004Q2 | 8.1 million USD | 212.6 million USD |
2004Q1 | 17.7 million USD | 230.7 million USD |
2003Q4 | 38.2 million USD | 245.1 million USD |
2003Q3 | 16.5 million USD | 209.8 million USD |
2003Q2 | 4.3 million USD | 182.6 million USD |
2003Q1 | 14.1 million USD | 202.6 million USD |
2002Q4 | 16.8 million USD | 227.5 million USD |
2002Q3 | 20.0 million USD | 213.2 million USD |
2002Q2 | 1.3 million USD | 182.0 million USD |
2002Q1 | 19.3 million USD | 198.5 million USD |
2001Q4 | 16.6 million USD | 228.7 million USD |
2001Q3 | 13.1 million USD | 217.1 million USD |
2001Q2 | 6.2 million USD | 177.3 million USD |
2001Q1 | 10.1 million USD | 192.0 million USD |
2000Q4 | 820000 USD | 190.9 million USD |
2000Q3 | 10.5 million USD | 193.3 million USD |
2000Q2 | -8.1 million USD | 150.5 million USD |
2000Q1 | 6.4 million USD | 181.5 million USD |
1999Q4 | 11.0 million USD | 197.2 million USD |
1999Q3 | 10.0 million USD | 209.4 million USD |
1999Q2 | -3.0 million USD | 187.8 million USD |
1999Q1 | 9.7 million USD | 251.4 million USD |
1998Q4 | 7.1 million USD | 226.1 million USD |
1998Q3 | -12.4 million USD | 212.3 million USD |
1998Q2 | -88.7 million USD | 214.4 million USD |
1998Q1 | 9.5 million USD | 223.7 million USD |
1997Q4 | 14.4 million USD | 240.7 million USD |
1997Q3 | 13.2 million USD | 223.8 million USD |
1997Q2 | 9.0 million USD | 196.2 million USD |
1997Q1 | 11.6 million USD | 214.6 million USD |
1996Q4 | 13.7 million USD | 221.7 million USD |
1996Q3 | 10.7 million USD | 212.2 million USD |
1996Q2 | 4.8 million USD | 175.6 million USD |
1996Q1 | 10.6 million USD | 196.3 million USD |
1995Q4 | 12.2 million USD | 201.0 million USD |
1995Q3 | 12.2 million USD | 205.1 million USD |
1995Q2 | 5.4 million USD | 174.4 million USD |
1995Q1 | 11.4 million USD | 185.3 million USD |
1994Q4 | 12.9 million USD | 174.7 million USD |
1994Q3 | 14.8 million USD | 182.7 million USD |
1994Q2 | 11.6 million USD | 158.2 million USD |
1994Q1 | 13.3 million USD | 163.6 million USD |
1993Q4 | 15.3 million USD | 174.4 million USD |
1993Q3 | 14.6 million USD | 173.1 million USD |
1993Q2 | 11.2 million USD | 144.7 million USD |
1993Q1 | 11.3 million USD | 142.2 million USD |
1992Q4 | 11.8 million USD | 141.0 million USD |
1992Q3 | 10.4 million USD | 142.9 million USD |
1992Q2 | 7.6 million USD | 108.8 million USD |
1992Q1 | 8.2 million USD | 120.8 million USD |
1991Q4 | 6.7 million USD | 93.0 million USD |
1991Q3 | ? USD | 87.1 million USD |
PRGO Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -12.7 million USD | 4.7 billion USD |
2022 | -130.9 million USD | 4.5 billion USD |
2021 | -130.9 million USD | 4.1 billion USD |
2020 | -162.6 million USD | 5.1 billion USD |
2019 | 146.1 million USD | 4.8 billion USD |
2018 | 131.0 million USD | 4.7 billion USD |
2017 | 119.6 million USD | 4.9 billion USD |
2016 | -4.0 billion USD | 5.3 billion USD |
2015 | 127.9 million USD | 4.6 billion USD |
2014 | 205.3 million USD | 4.1 billion USD |
2013 | 205.3 million USD | 4.1 billion USD |
2012 | 441.9 million USD | 3.5 billion USD |
2011 | 401.6 million USD | 3.2 billion USD |
2010 | 339.2 million USD | 2.8 billion USD |
2009 | 222.5 million USD | 2.3 billion USD |
2008 | 144.0 million USD | 2.0 billion USD |
2007 | 135.8 million USD | 1.8 billion USD |
2006 | 73.8 million USD | 1.4 billion USD |
2005 | 71.4 million USD | 1.4 billion USD |
2004 | -353.0 million USD | 1.0 billion USD |
2003 | 80.6 million USD | 898.2 million USD |
2002 | 54.0 million USD | 826.0 million USD |
2001 | 50.2 million USD | 826.3 million USD |
2000 | 27.7 million USD | 753.5 million USD |
1999 | 19.3 million USD | 738.6 million USD |
1998 | 1.5 million USD | 877.6 million USD |
1997 | -51.6 million USD | 902.6 million USD |
1996 | 45.0 million USD | 844.6 million USD |
1995 | 39.8 million USD | 778.1 million USD |
1994 | 44.4 million USD | 717.1 million USD |
1993 | 54.8 million USD | 669.3 million USD |
1992 | 44.6 million USD | 570.8 million USD |
1991 | 28.6 million USD | 409.8 million USD |
PRGO
List: Contenders
Price: 32.19USD
Dividend Yield: 3.47%
Forward Dividend Yield: 3.48%
Payout Ratio: 1365.00%
Dividend Per Share: 1.10 USD
Earnings Per Share: 0.08 USD
P/E Ratio: 394.50
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 680000
Ebitda: 274.7 millionMarket Capitalization: 4.3 billion
Average Dividend Frequency: 4
Years Paying Dividends: 22
DGR3: 7.19%
DGR5: 9.50%
DGR10: 12.02%